Ou Bai

12PUBLICATIONS
53CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHumoural immunology and immunochemistryHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 13, 2026
Development and Validation of a Novel Geriatric Risk Score for Prognostication in Older Patients With Hodgkin Lymphoma: A Multicenter Retrospective Study.

|Aug 11, 2026
Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective Study.

|Apr 18, 2026
Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS Lymphoma.

|Jan 09, 2026
Polyethylene glycol-conjugated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) primary prophylaxis significantly reduces the duration of neutropenia in non-Hodgkin's lymphoma patients treated with chemotherapy: a randomised trial (NCT05834751).

Bowen Wang, Luming Cao, Jia Li

|Sep 27, 2024
Time to lymphoma treatment within 24 months in 'watch and wait' follicular lymphoma is associated with inferior outcomes: A multicentre analysis.

Jing Liu, Fenghua Gao, Tingting Zhang

|May 16, 2024
Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.

Zhaoxia Li, Wei Guo, Yangzhi Zhao

Pageof 2

Frequent Collaborators

3 joint publications

Wei Guo

2 joint publications

Hui Zhou

1 joint publications

Xinxing Huang

1 joint publications

Fei Sun